Oncosuppressive functions of decorin

The extracellular matrix is rapidly emerging as a prominent contributor to various fundamental processes of tumorigenesis. In particular, decorin, a member of the small leucine-rich proteoglycan gene family, is assuming a central role as a potent soluble tumor repressor. Decorin binds and antagonizes various receptor tyrosine kinases and inhibits downstream oncogenic signaling in several solid tumors. Among other functions, decorin evokes cell cycle arrest, apoptosis, and antimetastatic, and antiangiogenic programs. Recent work has revealed a paradigmatic shift in our understanding of the molecular mechanisms underlying its tumoricidal properties. Decorin adversely compromises the genetic signature of the tumor microenvironment and induces endothelial cell autophagy downstream of VEGFR2. Moreover, decorin selectively evokes destruction of tumor cell mitochondria downstream of Met through mitophagy. Acting as a partial agonist, decorin signals via proautophagic receptors and triggers procatabolic processes that parallel the classical tumoricidal properties of this multifaceted proteoglycan.

[1]  R. Iozzo,et al.  Soluble biglycan as a biomarker of inflammatory renal diseases. , 2014, The international journal of biochemistry & cell biology.

[2]  V. Karantza,et al.  Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways , 2014, Oncogene.

[3]  R. Iozzo,et al.  Instructive roles of extracellular matrix on autophagy. , 2014, The American journal of pathology.

[4]  C. Perou,et al.  c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer , 2014, Oncogene.

[5]  L. Zender,et al.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles , 2014, Nature.

[6]  C. López-Otín,et al.  The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21 , 2014, Oncogene.

[7]  R. Iozzo,et al.  Endorepellin Evokes Autophagy in Endothelial Cells* , 2014, The Journal of Biological Chemistry.

[8]  R. Iozzo,et al.  Decorin differentially modulates the activity of insulin receptor isoform A ligands. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[9]  M. Young,et al.  Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[10]  R. Iozzo,et al.  A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[11]  M. Young,et al.  Biglycan modulates angiogenesis and bone formation during fracture healing. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[12]  J. Pfeilschifter,et al.  Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[13]  R. Langer,et al.  Matrilin-1 Is an Inhibitor of Neovascularization* , 2014, The Journal of Biological Chemistry.

[14]  I. Kovalszky,et al.  Decorin deficiency promotes hepatic carcinogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[15]  R. Iozzo,et al.  De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[16]  F. Pontén,et al.  Decreased decorin expression in the tumor microenvironment , 2014, Cancer medicine.

[17]  R. Iozzo,et al.  Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[18]  J. Hoek,et al.  Decorin Induces Mitophagy in Breast Carcinoma Cells via Peroxisome Proliferator-activated Receptor γ Coactivator-1α (PGC-1α) and Mitostatin* , 2014, The Journal of Biological Chemistry.

[19]  Klaus Eckert,et al.  Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome. , 2013, Cell reports.

[20]  P. Boström,et al.  Lack of Decorin Expression by Human Bladder Cancer Cells Offers New Tools in the Therapy of Urothelial Malignancies , 2013, PloS one.

[21]  Clayton J. Underwood,et al.  Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[22]  M. Duncan Extracellular matrix transcriptome dynamics in hepatocellular carcinoma. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[23]  N. Grishin,et al.  EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance , 2013, Cell.

[24]  R. Iozzo,et al.  Decorin has an appetite for endothelial cell autophagy , 2013, Autophagy.

[25]  E. Brandan,et al.  Role of skeletal muscle proteoglycans during myogenesis. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[26]  H. Ditzel,et al.  Decorin is down‐regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF‐induced myeloma plasma cell viability and migration , 2013, European journal of haematology.

[27]  R. Iozzo,et al.  Decorin causes autophagy in endothelial cells via Peg3 , 2013, Proceedings of the National Academy of Sciences.

[28]  Norihiro Suzuki,et al.  Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation* , 2013, The Journal of Biological Chemistry.

[29]  R. Iozzo,et al.  Decorin induces rapid secretion of thrombospondin‐1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho‐associated coiled‐coil containing protein kinase 1 , 2013, The FEBS journal.

[30]  R. Iozzo,et al.  Dichotomy of decorin activity on the insulin‐like growth factor‐I system , 2013, The FEBS journal.

[31]  R. Iozzo,et al.  Biological interplay between proteoglycans and their innate immune receptors in inflammation , 2013, The FEBS journal.

[32]  I. Kovalszky,et al.  Decorin interferes with platelet‐derived growth factor receptor signaling in experimental hepatocarcinogenesis , 2013, The FEBS journal.

[33]  Gennifer E. Merrihew,et al.  The PINK1–Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo , 2013, Proceedings of the National Academy of Sciences.

[34]  Jun S. Song,et al.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.

[35]  P. Puigserver,et al.  PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. , 2013, Cancer cell.

[36]  P. Keely,et al.  Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[37]  G. Bhagat,et al.  Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation , 2012, Science.

[38]  M. Mohammadi,et al.  Grb2, a Double-Edged Sword of Receptor Tyrosine Kinase Signaling , 2012, Science Signaling.

[39]  R. Youle,et al.  Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. , 2012, Cold Spring Harbor perspectives in biology.

[40]  R. Iozzo,et al.  Endorepellin Affects Angiogenesis by Antagonizing Diverse Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-evoked Signaling Pathways , 2012, The Journal of Biological Chemistry.

[41]  A. Purushothaman,et al.  Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma* , 2012, The Journal of Biological Chemistry.

[42]  P. Boström,et al.  Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast , 2012, Histochemistry and Cell Biology.

[43]  R. Vadigepalli,et al.  Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model , 2012, PloS one.

[44]  W. Becker Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control , 2012, Cell cycle.

[45]  P. Lala,et al.  Mechanisms in Decorin Regulation of Vascular Endothelial Growth Factor-Induced Human Trophoblast Migration and Acquisition of Endothelial Phenotype1 , 2012, Biology of reproduction.

[46]  N. Karamanos,et al.  The Biology of Small Leucine-rich Proteoglycans in Bone Pathophysiology* , 2012, The Journal of Biological Chemistry.

[47]  O. Grace,et al.  Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer , 2012, PloS one.

[48]  R. Iozzo,et al.  Decorin: a guardian from the matrix. , 2012, The American journal of pathology.

[49]  G. Hunnicutt,et al.  Trainee Forum—Writing Winning Grants. , 2012 .

[50]  T. Walther,et al.  The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.

[51]  R. Iozzo,et al.  Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation , 2012, Cell cycle.

[52]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[53]  N. Shinohara,et al.  Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells , 2012, British Journal of Cancer.

[54]  A. Ballabio,et al.  A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.

[55]  R. Iozzo,et al.  The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. , 2012, Blood.

[56]  R. Iozzo,et al.  Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. , 2012, Current opinion in genetics & development.

[57]  I. Kovalszky,et al.  Decorin–TGFβ Axis in Hepatic Fibrosis and Cirrhosis , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[58]  R. Iozzo,et al.  3.5 Small leucine-rich proteoglycans: multifunctional signaling effectors , 2012 .

[59]  H. Yao,et al.  HGF-Induced PKCζ Activation Increases Functional CXCR4 Expression in Human Breast Cancer Cells , 2012, PloS one.

[60]  M. Lisanti,et al.  Decorin Antagonizes the Angiogenic Network , 2011, The Journal of Biological Chemistry.

[61]  K. Schäfers,et al.  The Role for Decorin in Delayed-Type Hypersensitivity , 2011, The Journal of Immunology.

[62]  J. Pfeilschifter,et al.  Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21 , 2011, Science Signaling.

[63]  S. Wesselborg,et al.  Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks , 2011, Molecular and Cellular Biology.

[64]  J. Tovey,et al.  Targeted Decorin Gene Therapy Delivered with Adeno-Associated Virus Effectively Retards Corneal Neovascularization In Vivo , 2011, PloS one.

[65]  C. Stock,et al.  Decorin and chondroitin‐6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification , 2011, Journal of cellular physiology.

[66]  R. Iozzo,et al.  Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling* , 2011, The Journal of Biological Chemistry.

[67]  L. Schaefer Small leucine-rich proteoglycans in kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[68]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[69]  G. M. Di Guglielmo,et al.  Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. , 2011, Molecular endocrinology.

[70]  K. Sekiguchi,et al.  Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the α2β1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) , 2011, The Journal of Biological Chemistry.

[71]  M. Rugge,et al.  Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells , 2011, PloS one.

[72]  Renato V Iozzo,et al.  Proteoglycans in cancer biology, tumour microenvironment and angiogenesis , 2011, Journal of cellular and molecular medicine.

[73]  S. Davies,et al.  Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue. , 2011, Brain : a journal of neurology.

[74]  N. Brüggemann,et al.  Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts , 2011, PloS one.

[75]  Cinzia L. Marchica,et al.  A role for decorin in a murine model of allergen-induced asthma. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[76]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[77]  I. Kovalszky,et al.  Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice , 2011, Laboratory Investigation.

[78]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[79]  Hong-Gang Wang,et al.  The Association of AMPK with ULK1 Regulates Autophagy , 2010, PloS one.

[80]  L. Scorrano,et al.  Trichoplein/mitostatin regulates endoplasmic reticulum–mitochondria juxtaposition , 2010, EMBO reports.

[81]  R. Iozzo,et al.  Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels* , 2010, The Journal of Biological Chemistry.

[82]  R. Iozzo,et al.  Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans , 2010, The FEBS journal.

[83]  Qing Jun Wang,et al.  The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. , 2010, Trends in cell biology.

[84]  Angela C. Poole,et al.  The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway , 2010, PloS one.

[85]  M. Komatsu,et al.  Physiological significance of selective degradation of p62 by autophagy , 2010, FEBS letters.

[86]  Fabienne C. Fiesel,et al.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.

[87]  Mark D. Johnson,et al.  The Imprinted Gene PEG3 Inhibits Wnt Signaling and Regulates Glioma Growth* , 2010, The Journal of Biological Chemistry.

[88]  T. Kyriakides,et al.  The role of thrombospondins in wound healing, ischemia, and the foreign body reaction , 2009, Journal of Cell Communication and Signaling.

[89]  J. Pfeilschifter,et al.  Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[90]  R. Iozzo,et al.  Decorin is a novel antagonistic ligand of the Met receptor , 2009, The Journal of cell biology.

[91]  David S. Park,et al.  Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission* , 2009, Journal of Biological Chemistry.

[92]  R. Iozzo,et al.  Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and Biglycan* , 2009, Journal of Biological Chemistry.

[93]  R. Iozzo,et al.  A Central Role for Decorin during Vertebrate Convergent Extension* , 2008, Journal of Biological Chemistry.

[94]  R. Iozzo,et al.  Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifs , 2008, International journal of cancer.

[95]  L. Scorrano,et al.  MITOSTATIN, a Putative Tumor Suppressor on Chromosome 12q24.1, is Down-regulated in Human Bladder and Breast Cancer , 2008, Oncogene.

[96]  M. Fassan,et al.  An antimetastatic role for decorin in breast cancer. , 2008, The American journal of pathology.

[97]  A. Garnier,et al.  Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. , 2008, Cardiovascular research.

[98]  L. Heilbronn,et al.  Decorin is a secreted protein associated with obesity and type 2 diabetes , 2008, International Journal of Obesity.

[99]  S. Yaccoby,et al.  Role of decorin in the antimyeloma effects of osteoblasts. , 2008, Blood.

[100]  Wancai Yang,et al.  Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. , 2008, Carcinogenesis.

[101]  M. Söderström,et al.  Differential Expression of Decorin by Human Malignant and Benign Vascular Tumors , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[102]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[103]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[104]  R. Hynes Cell–matrix adhesion in vascular development , 2007, Journal of thrombosis and haemostasis : JTH.

[105]  N. Davidson,et al.  The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. , 2007, Gastroenterology.

[106]  R. Iozzo,et al.  Decorin Protein Core Inhibits in Vivo Cancer Growth and Metabolism by Hindering Epidermal Growth Factor Receptor Function and Triggering Apoptosis via Caspase-3 Activation* , 2006, Journal of Biological Chemistry.

[107]  L. Soslowsky,et al.  Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development , 2006, Journal of cellular biochemistry.

[108]  R. Iozzo,et al.  A role for decorin in cutaneous wound healing and angiogenesis , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[109]  S. Pattingre,et al.  Bcl-2 inhibition of autophagy: a new route to cancer? , 2006, Cancer research.

[110]  J. Folkman,et al.  Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. , 2006, Experimental cell research.

[111]  Carlos Cordon-Cardo,et al.  Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  David I. Smith,et al.  Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. , 2005, Gynecologic oncology.

[113]  Charles C. Reed,et al.  Decorin Evokes Protracted Internalization and Degradation of the Epidermal Growth Factor Receptor via Caveolar Endocytosis* , 2005, Journal of Biological Chemistry.

[114]  M. Stallcup,et al.  Activation of nuclear receptor coactivator PGC-1α by arginine methylation , 2005 .

[115]  R. Iozzo,et al.  Decorin, a Novel Player in the Insulin-like Growth Factor System* , 2005, Journal of Biological Chemistry.

[116]  R. Iozzo,et al.  Decorin prevents metastatic spreading of breast cancer , 2005, Oncogene.

[117]  S. Thanos,et al.  Decorin Deficiency Leads to Impaired Angiogenesis in Injured Mouse Cornea , 2004, Journal of Vascular Research.

[118]  S. Lipkowitz,et al.  A Conserved DpYR Motif in the Juxtamembrane Domain of the Met Receptor Family Forms an Atypical c-Cbl/Cbl-b Tyrosine Kinase Binding Domain Binding Site Required for Suppression of Oncogenic Activation* , 2004, Journal of Biological Chemistry.

[119]  Mogens Kruhøffer,et al.  Gene Expression in the Urinary Bladder , 2004, Cancer Research.

[120]  R. Iozzo,et al.  Biologically Active Decorin Is a Monomer in Solution* , 2004, Journal of Biological Chemistry.

[121]  R. Iozzo,et al.  Decorin Binds to a Narrow Region of the Epidermal Growth Factor (EGF) Receptor, Partially Overlapping but Distinct from the EGF-binding Epitope* , 2002, The Journal of Biological Chemistry.

[122]  R. Iozzo,et al.  Decorin suppresses tumor cell-mediated angiogenesis , 2002, Oncogene.

[123]  R. Iozzo,et al.  Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin , 2002, Oncogene.

[124]  T. Yamashita,et al.  Peg3/Pw1 Is Involved in p53-mediated Cell Death Pathway in Brain Ischemia/Hypoxia* , 2002, The Journal of Biological Chemistry.

[125]  S Kobayashi,et al.  Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[126]  R. Iozzo,et al.  An Anti-oncogenic Role for Decorin , 2000, The Journal of Biological Chemistry.

[127]  L C Murphy,et al.  Lumican and decorin are differentially expressed in human breast carcinoma , 2000, The Journal of pathology.

[128]  M. Nugent,et al.  Sustained Down-regulation of the Epidermal Growth Factor Receptor by Decorin , 2000, The Journal of Biological Chemistry.

[129]  J. Schlessinger Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[130]  Pll Siinksen,et al.  Control , 1999, Netherlands Journal of Plant Pathology.

[131]  Anthony J. Guidi,et al.  Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[132]  B. Calabretta,et al.  Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[133]  R. Iozzo,et al.  Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[134]  R. Iozzo,et al.  Decorin Activates the Epidermal Growth Factor Receptor and Elevates Cytosolic Ca2+ in A431 Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[135]  R. Iozzo,et al.  Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. , 1998, The Journal of clinical investigation.

[136]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[137]  M. Surani,et al.  Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein , 1996, Nature Genetics.

[138]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[139]  C. Purdie,et al.  Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. , 1994, Oncogene.

[140]  R. Iozzo,et al.  Neoplastic modulation of extracellular matrix: Stimulation of chondroitin sulfate proteoglycan and hyaluronic acid synthesis in co‐cultures of human colon carcinoma and smooth muscle cells , 1989, Journal of cellular biochemistry.

[141]  R. Iozzo,et al.  Isolation and characterization of proteoglycans synthesized by human colon and colon carcinoma. , 1982, The Journal of biological chemistry.

[142]  R P Bolender,et al.  Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and stereologic analysis. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[143]  A. Wells,et al.  Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion , 2014, Laboratory Investigation.

[144]  Mark R. Buckley,et al.  Decorin expression is important for age-related changes in tendon structure and mechanical properties. , 2013, Matrix biology : journal of the International Society for Matrix Biology.

[145]  S. Ryter,et al.  Autophagy in human health and disease. , 2013, The New England journal of medicine.

[146]  R. Iozzo,et al.  Small Leucine-Rich Proteoglycans , 2011 .

[147]  J. Schlessinger,et al.  Signaling by Receptor Tyrosine Kinases , 1993 .